Xencor | XNCR - Loan Capital

Stock Price
11.61
Daily Change
0.79 7.30%
Monthly
-22.34%
Yearly
-31.87%
Q1 Forecast
11.72

Xencor reported $87.78M in Loan Capital for its fiscal quarter ending in September of 2025.





Loan Capital Change Date
AbbVie USD 62.97B 12M Sep/2025
Alnylam Pharmaceuticals USD 1.04B 13.75M Sep/2025
Amgen USD 52.43B 1.33B Sep/2025
Arrowhead Research USD 538.1M 323.22M Dec/2025
AstraZeneca USD 6.55B 19.43B Sep/2025
Biogen USD 6.29B 1.4M Sep/2025
Bristol-Myers Squibb USD 42.85B 1.62B Dec/2025
Cytokinetics USD 158.75M 554.3M Sep/2025
GlaxoSmithKline GBP 14.71B 186M Dec/2025
J&J USD 39.41B 173M Sep/2025
MacroGenics USD 70.26M 4K Sep/2025
Merck USD 39.97B 6B Sep/2025
Novartis USD 24.24B 174M Sep/2025
Pfizer USD 57.41B 93M Sep/2025
Regeneron Pharmaceuticals USD 2.71B 720.4M Dec/2025
Roche Holding CHF 27.43B 966M Dec/2025
Xencor USD 87.78M 6.96M Sep/2025